ASND Stock Ownership Activity

ASCENDIS PHARMA A/S - ADR 13F holders

1 value investing guru has made changes to the ASCENDIS PHARMA A/S - ADR (ASND) position according to the gurus' latest SEC quarterly report(s). ASND has been bought (as a new position) by 1 guru(s)

Which gurus or hedge funds are buying ASND now?

According to the latest SEC filing(s) ASCENDIS PHARMA A/S - ADR (ASND) has been bought by David M. Polen - Polen Capital Management (new buy).

To see more about who is investing in ASCENDIS PHARMA A/S - ADR (ASND), please go to the ASND ownership page.

History
Name
Company
%
Activity
Share
Change
% change to
Portfolio
% of
Portfolio
2025 Q2 (1 result)
David M. Polen
Polen Capital Management
buy
+2,719
+0.00%
0.00%
Current price: $194.30 12.57% Reported price*: $172.60
2021 Q4 (1 result)
Stephen Mandel
Lone Pine Capital
-100.00%
-1,436,981
-0.94%
0.00%
Current price: $194.30 21.90% Reported price*: $159.39
2021 Q1 (1 result)
Stephen Mandel
Lone Pine Capital
+60.64%
+542,448
+0.25%
0.67%
Current price: $194.30 50.76% Reported price*: $128.88
2020 Q4 (1 result)
Stephen Mandel
Lone Pine Capital
buy
+894,533
+0.54%
0.54%
Current price: $194.30 16.50% Reported price*: $166.78
4 of 4

Shares, change to shares, sold shares - split-adjusted.

Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.

Value or Price - If the security is completely sold out, we show the reported value (or price) prior to the actual period.